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Animal studies indicate gonadal hormones at puberty have an effect on the development of 
masculine and feminine traits. However, it is unknown whether similar processes occur in 
humans. We examined whether women with anorexia nervosa (AN), who often experience 
primary amenorrhea, exhibit attenuated feminization in their psychological characteristics in 
adulthood due to the decrease/absence of gonadal hormones at puberty. Women with AN were 
compared on a number of psychological characteristics using General Linear Models based on the 
presence/absence of primary amenorrhea. Although women with primary amenorrhea exhibited 
lower anxiety scores than those without primary amenorrhea, in general, results did not provide 
evidence of attenuated feminization in women with AN with primary amenorrhea. Future research 
should utilize novel techniques and direct hormone measurement to explore the effects of pubertal 
gonadal hormones on masculine and feminine traits.
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The etiology of anorexia nervosa (AN) and other sex-differentiated disorders (e.g., 
depression) remains largely unknown. (Hudson, Hiripi, Pope, & Kessler, 2007; Kessler et 
al., 1994) A relatively unexplored area in this regard is gonadal hormone effects, which have 
been found to exert significant influences on sex-differentiated behavior (for recent reviews 
see (Berenbaum & Beltz, 2011; Hines, 2011; Sisk & Zehr, 2005). For example, in 1959, 
Phoenix (Phoenix, Roy, Gerall, & Young, 1959) posited that gonadal hormones affect the 
brain and behavior in two fundamentally different ways–in an organizational and an 
activational manner. During specific points in development (e.g., prenatal/perinatal periods), 
exposure to gonadal hormones will organize neural circuits such that testosterone 
masculinizes neural circuits in males, whereas the absence of testosterone results in the 
feminization of neural circuits in females. Organizational effects persist beyond the period 
of hormone exposure and do not require the continued presence of the hormone. 
Organizational effects also program sex typical behavioral and physiological responses to 
gonadal hormones later in life. These responses are referred to as activational effects, which 
are transient in nature, and require the continued presence of hormone to be maintained.
Organizational effects have been confirmed by a multitude of experimental animal studies 
where neonatal or prepubertal castration of rodents results in males who are “feminized” (in 
mating behaviors, aggressiveness, play fighting), (Beach & Holz, 1946; Peters, Bronson, & 
Whitsett, 1972; Schulz & Sisk, 2004; Taylor, Frechmann, & Royalty, 1986) while perinatal 
testosterone injections in female animals result in masculine juvenile play, sexual, and 
aggressive behaviors. (Cohen-Bendahan, van de Beek, & Berenbaum, 2005; Phoenix, et al., 
1959; Schulz & Sisk, 2004) In humans, the organizational effects of prenatal hormones have 
been examined in populations with congenital conditions that affect reproductive hormones. 
For example, women with congenital adrenal hyperplasia (CAH; prenatal androgen excess) 
display more interest in male typical behaviors and personality characteristics (e.g. 
aggression) and perform better on spatial tasks compared to women without CAH. 
(Berenbaum, Bryk, & Beltz, 2012; Hines, 2011; Mueller, 2013)
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Despite the robustness of the results from animal studies, and the intriguing findings from 
human models, more work is needed in translating these findings to human populations. 
However, exploring the impact of gonadal hormones on behavior in humans is difficult 
because we are unable to manipulate the reproductive system in humans as can be done in 
animals. A possible strategy for examining these effects in humans is to explore proxies, 
such as a delayed pubertal onset. (Berenbaum & Beltz, 2011) This design is particularly 
important, as puberty is believed to be an additional period of development when gonadal 
hormones organize the nervous system and influence brain and behavior development in 
humans. (Hines, 2011; Neufang et al., 2009; Schulz, Molenda-Figueira, & Sisk, 2009; Sisk 
& Zehr, 2005) In animals, hamsters that have their testes removed after the perinatal period 
of sexual differentiation and before puberty behave in a less masculinized manner (e.g., 
reduced sexual and aggressive behavior), and prolonged testosterone replacement after 
puberty fails to normalize these behaviors. (Schulz & Sisk, 2004) Although studied less 
extensively, similar patterns are emerging in females such that a pre-pubertal ovariectomy in 
female rats results in male-like food guarding strategies that do not change with exogenous 
ovarian hormone exposure in adulthood. (Field, Whishaw, Forgie, & Pellis, 2004) Further, a 
recent report in a sample of adolescents with AN observed that reductions in gray matter in 
the brain during acute AN are reversible upon weight restoration and the increase of certain 
gonadal hormones (i.e., follicle-stimulating hormone). (Mainz, Schulte-Ruther, Fink, 
Herpertz-Dahlmann, & Konrad, 2012) Together, these results suggest puberty is a time 
sensitive window for hormone organization and brain development.
Women with AN frequently experience primary amenorrhea, (Pinheiro et al., 2007) defined 
as menarche after age sixteen. (Master-Hunter & Heiman, 2006) Primary amenorrhea is a 
natural occurring phenomenon that can be explored to examine the behavioral effects of a 
partially or permanently delayed pubertal onset, which may stall the developmental process 
entirely. However, primary amenorrhea is uncommon, making this difficult to explore in 
population-based samples. Thus, because women with AN frequently experience primary 
amenorrhea, this population may represent a proxy population, where an adequate sample of 
women with primary amenorrhea can be obtained, to explore the organizational effects of 
gonadal steroids on sex-differentiated behavior. Using this proxy model, if organizational 
effects at puberty do affect sex differences in behavior, we expect women with AN who 
experienced primary amenorrhea to exhibit increased male typical behaviors and 
characteristics in adulthood. In other words, these women may be permanently 
“defeminized” due to the absence of organizational effects of gonadal hormones during 
adolescent brain development.
We explore this possibility by comparing adult women with AN, with and without primary 
amenorrhea, on a number of psychological disorders and personality traits that are 
characteristic of women (i.e., depression, anxiety) or men (i.e., substance use disorders). 
(Kessler, et al., 1994) If adolescence is a sensitive period for pubertal hormones to organize 
sex typical behaviors, we expect elevated male typical disorders and traits in women with 
AN who experienced primary amenorrhea. Although the main focus of our report is on the 
effects of primary amenorrhea on sex typical behavior (using AN as a proxy population), an 
added benefit is that we are also able to examine the effects of primary amenorrhea on AN 
features that may have significant clinical implications.
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Participants were women from the NIH funded Genetics of Anorexia Nervosa Study. A 
detailed description of this investigation can be found elsewhere. (Kaye et al., 2008) This 
study was approved by local Institutional Review Boards and Ethics Boards. All participants 
provided informed consent prior to participation.
Probands were at least 16 years old, ill with or recovered from a lifetime diagnosis of DSM-
IV AN, with or without amenorrhea, at least three years prior to study entry and by age 45. 
Low weight was defined as a body mass index (BMI) at or below 18 kg/m2 for women, 
which corresponds to the 5th percentile BMI values of the NHANES (Hebebrand, 
Himmelmann, Heseker, Schafer, & Remschmidt, 1996) epidemiological sample of women 
aged 27 to 29 years, the average age of probands in our previous studies. (Kaye et al., 2000) 
Probands were required to have at least one first, second, or third degree relative with AN 
(excluding parents and MZ twins) willing to participate in the study. Exclusion criteria for 
probands were: regular binge eating (binge eating episodes occurring at least twice a week 
for at least three months); a maximum lifetime BMI exceeding 30 kg/m2; a history of severe 
central nervous system trauma that renders diagnosis uncertain; psychotic disorder or 
developmental disability; or a medical, neurological or substance use disorder that may 
confound the diagnosis of AN or interfere with responding cogently to assessments.
Inclusion criteria for affected family members were identical except that relatives were 
permitted to engage in regular binge eating, did not have to meet AN criteria three years 
prior to the study, and could have an additional lifetime diagnosis of bulimia nervosa (BN). 
However, affected family members were required to have maintained a low weight for at 
least three months. Additional relatives with eating disorders could be included in the study 
once a proband and a relative meeting inclusion criteria were enrolled.
Measures
Anorexia Nervosa Pathology—Lifetime AN diagnoses, inclusion/exclusion criteria, 
and current illness status (presence of at least one AN symptom in the last year were 
categorized as currently ill) were assessed using a modified version of Module H of the 
Structured Clinical Interview for Axis I Disorders (SCID-I). (First, Spitzer, Gibbon, & 
Williams, 1997) The Structured Interview for Anorexia Nervosa and Bulimic Syndromes 
(Fichter, Herpertz, Quadflieg, & Herpertz-Dahlmann, 1998) was used to confirm lifetime 
AN diagnosis and obtain age at menarche, age at lowest weight, current BMI, lifetime 
lowest illness-related BMI, and lifetime highest BMI. From these assessments, the following 
AN subtypes were created: (1) AN restricting type (AN with no regular binge eating or 
purging, defined as fewer than five times ever), (2) AN purging type (AN with purging but 
no regular binge eating (i.e., fewer than five times ever)), (3) AN binge/purge type (AN with 
regular binge eating and/or purging), and (4) lifetime history of both AN and BN.
We constructed two menstrual status variables for analysis. First, we coded primary 
amenorrhea as present if menarche occurred at or after age 16, and primary amenorrhea as 
absent if menarche occurred before age 16. This definition of primary amenorrhea is based 
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on the current typical chronological age for age at menarche. (Master-Hunter & Heiman, 
2006; McDowell, Brody, & Hughes, 2007) Second, in an effort to rule out the possibility 
that significant effects were due to early onset AN, we explored group differences based on 
the ordering of age of AN onset versus age of menarche (‘AN-menses onset’). The groups 
included: (1) no menarche onset by age 16, with AN onset prior to the onset of menarche 
(i.e., primary amenorrhea with AN onset occurring before menarche (PRIME-AN1MN2)); 
(2) no menarche onset by age 16, with AN onset after the onset of menarche (i.e., primary 
amenorrhea with AN onset occurring after menarche (PRIME-AN2MN1); (3) menarche 
onset by age 16, with AN onset prior to the onset of menarche (i.e., no primary amenorrhea 
with AN onset occurring before menarche (AN1MN2); (4) menarche onset by age 16, with 
AN onset after the onset of menarche (i.e., no primary amenorrhea with AN onset occurring 
after menarche (AN2MN1).
Personality and Symptom Measures—The Temperament and Character Inventory 
(TCI) (Cloninger, Przybeck, Svrakic, & Wetzel, 1994) was used to assess the personality 
dimensions of novelty seeking and harm avoidance. Impulsivity was evaluated using the 
cognitive, nonplanning, and motor subscales of the Barratt Impulsiveness Scale-11 (BIS), 
(Patton, Stanford, & Barratt, 1995) and the State-Trait Anxiety Inventory Form Y (STAI-Y) 
(Spielberger, Gorsuch, & Luchene, 1970) was used to assess state anxiety. Obsessions and 
compulsions were examined using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), 
(Goodman et al., 1989) which is a semi-structured interview designed to rate the presence 
and severity of obsessions and compulsions typically found among individuals with 
obsessive-compulsive disorder.
Psychiatric and Substance Use Disorders—DSM-IV lifetime history of major 
depression was assessed with the Diagnostic Interview for Genetics Studies. (Nurnberger et 
al., 1994) The SCID-I was used to assess DSM-IV defined anxiety disorders (agoraphobia, 
generalized anxiety disorder, obsessive compulsive disorder, panic disorder, post-traumatic 
stress disorder, social phobia and specific phobia) and substance disorders. An ‘any anxiety 
disorder’ variable was created indicating whether the individual met, in their lifetime, 
criteria for any of the listed anxiety disorders. Psychoactive substance use disorder was 
considered present if a participant met criteria for abuse or dependence of sedatives, 
hallucinogens, stimulants, cocaine, marijuana, or opioids. Alcohol use disorder was similarly 
defined.
Statistical Procedures
General linear models using PROC GENMOD in SAS version 9.2 (SAS Institute Inc, 2004) 
were used to examine whether women with primary amenorrhea exhibit masculinized 
psychological characteristics, compared with women with no primary amenorrhea. 
Generalized estimating equation modeling (GEE) was applied to correct for the non-
independence of the family data. The specific methods used to implement GEE are detailed 
elsewhere. (Klump et al., 2000)
Our first set of models examined whether primary amenorrhea influenced scores on the 
dependent measures. Our second set of models were conducted on any personality and 
Baker et al. Page 5






















additional comorbidity measures that were significant in the first set of models and assessed 
group differences based on the ordering of age of AN onset versus age at menarche. Cohen’s 
d effect sizes were calculated for all results in the first set of models and for all significant 
results in the second set of models. Current illness status, duration of illness, age at 
interview, and AN subtype were included as covariates. Continuous variables were 
standardized prior to analysis.
RESULTS
Demographics
A total of 841 participants (388 probands and 453 relatives) were eligible for the current 
report. Sixty-five percent of participants reported an age of AN onset between the ages of 
11–17 years-old, with an average total duration of illness of 10 years and an average 
duration of illness of 3 years during the ages of 11–17. Thus, a majority of our participants 
had AN during adolescence, which spanned well beyond the adolescent years. 
Approximately 10% (n = 79) of the sample was classified as having primary amenorrhea. 
Mean age at the time of interview for those with primary amenorrhea was 28.89 (SD = 
10.41) years old and for those without primary amenorrhea was 29.72 (SD = 11.30) years 
old. Mean age at onset of menses was 17.46 years (SD = 2.29) for the primary amenorrhea 
group and 12.74 years (SD = 1.22) for the no primary amenorrhea group, the latter of which 
is similar to the population average. (McDowell, et al., 2007) A majority of the women with 
primary amenorrhea (71%; n = 56) reported AN onset prior to menarche and were placed in 
the PRIME-AN1MN2 group. The other 23 (29%) were placed in the PRIME-AN2MN1 
group. Of the women without primary amenorrhea, 74 (10%) reported AN onset prior to 
menarche and were placed in the AN1MN2 group, whereas the majority of the participants 
(90%, n = 622) were placed in the AN2MN1 group.
Individuals with primary amenorrhea differed significantly from those with no primary 
amenorrhea on several eating disorder features (Table 1). Those with primary amenorrhea 
were significantly younger at the time of lowest weight, had a lower lifetime lowest BMI, 
and had a longer duration of illness. There were no significant differences for current BMI 
or current illness status: 66% of women with primary amenorrhea and 68% of women 
without primary amenorrhea endorsed experiencing at least one eating disorder symptom in 
the year prior to the assessment suggesting the primary amenorrhea group likely did not 
have more severe eating disorder features at the time of interview.
Comparisons between AN with and without Primary Amenorrhea
Significant differences between the primary amenorrhea group and the no primary 
amenorrhea group were observed for TCI novelty seeking, BIS motor, and STAI state 
anxiety (Table 1). Contrary to hypotheses, the primary amenorrhea group scored 
significantly lower on these measures and effect sizes, in general, indicated a small-to-
medium effect. There were no significant differences between the amenorrhea groups for 
any psychiatric disorder (Table 2).
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We examined whether significant group differences in TCI novelty seeking, BIS motor, and 
STAI state anxiety were independent of the ordering of AN onset versus menarche (Table 
3). For novelty seeking the PRIME-AN1MN2 and PRIME-AN2MN1 groups differed 
significantly from the AN1MN2 group. For state anxiety, the PRIME-AN1MN2 group 
differed significantly from the AN1MN2 group, and the PRIME-AN2MN1 group differed 
significantly from both the AN1MN2 and AN2MN1 groups. For both measures the PRIME-
AN1MN2 and PRIME-AN2MN1 groups reported lower scores than the AN1MN2 and 
AN2MN1 group. AN2MN1 also scored significantly lower on state anxiety than the 
AN1MN2.
DISCUSSION
We examined the hypothesis that women with AN who experienced primary amenorrhea 
would display attenuated feminization in adulthood due to the organizational effects of 
gonadal hormones at puberty. In contrast to our hypothesis, we did not find evidence of 
attenuated feminization. Although we observed significant differences between women with 
and without primary amenorrhea on several personality characteristics, in general, results 
were in the opposite direction of attenuated feminization. Women with AN and primary 
amenorrhea scored lower on novelty seeking and impulsivity, both of which would be 
expected to be higher than those with normal menstrual onset if a defeminization effect was 
present.
More in line with our hypothesis, women with AN and primary amenorrhea exhibited lower 
levels of state anxiety. Although this finding aligns with those for general levels of anxiety 
exhibited in humans (McLean & Anderson, 2009), it is contrary to observations in women 
with Turner’s Syndrome (genetic disorder of androgen deficiency) who typically exhibit 
increased levels of anxiety, depression, and arousal in response to facial expressions of fear. 
(Schmidt, et al., 2006; Skuse, et al., 2005). We also observed no significant differences for 
any anxiety disorder diagnosis. This suggests that either defeminization is specific to state 
anxiety, or that the effect is spurious. Although the state anxiety group difference was of 
medium effect size, overall, our results do not provide convincing evidence for a 
defeminization effect.
There are several possible explanations for our largely null results. First, these effects are 
not present. Although animal studies have demonstrated significant evidence for 
organizational effects of gonadal hormones, most prominently in males, it is unclear how 
well results from animal studies translate to a human population and to females. Second, 
gonadal hormones at puberty have an organizational effect that our study was not able to 
capture. Although the significant differences we found remained regardless of the order of 
occurrence of AN and menarche, the extent and nature of the effects of AN on brain and 
behavior remain incompletely understood. For example, AN typically onsets during 
adolescence and having AN during this sensitive period may affect brain development, 
structure, and function (Buehren et al., 2011; Chui et al., 2008; Katzman et al., 1996; 
Katzman, Zipursky, Lambe, & Mikulis, 1997; Mainz, et al., 2012), suggesting that women 
with AN may have additional factors confounding the organizational effects of hormones. 
Further, within the PRIME-AN1MN2 group, it is possible that individuals experiencing 
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primary amenorrhea prior to AN diagnosis may have had a subthreshold diagnosis or 
undiagnosed/unreported symptoms, which may have limited our ability to observe a 
masculinization effect in this proxy sample.
Third, menarche occurs later in the pubertal process, on average two years after breast 
development begins. (Marshall & Tanner, 1969) This means that gonadal hormone levels 
begin to increase approximately two years prior to menses; therefore, menarche is a rough 
measure of hormonal influences, and our cutoff age of 16 for primary amenorrhea may still 
be within the sensitive period during which women are exposed to gonadal hormones. A 
study design utilizing a more significant delay in menarche, for example age 18 or older, 
may be necessary to delineate the organizational effects of gonadal hormones in humans—
although achieving adequate sample sizes would become increasingly challenging. For 
example, within our sample, only 24 participants reported an age of menarche at age 18 or 
older. When completing the analyses using this definition for primary amenorrhea, only 
novelty seeking remained significant. Importantly however, results remained in the same 
direction. Further, our definition of primary amenorrhea was unable to take into account 
secondary sexual characteristics and to be confirmed through hormone measurements.
Fourth, organizational effects at puberty may be phenotype specific. The animal literature 
provides convincing data showing an organizational effect on sex differences in anxiety. 
Whereas many phenotypes appear to be characteristically masculine or feminine in nature, 
the driving force behind this difference may not be attributable to organizational effects at 
puberty and may be the result of prenatal/perinatal hormone activation. Moreover, there are 
likely many biological and environmental factors that contribute to gender typical behaviors 
and characteristics, especially in humans. For example, in humans, sociocultural factors such 
as parenting or gender role beliefs may play a part in the development of masculine and 
feminine traits. Thus, defeminization effects might be phenotype specific and only observed 
in characteristically masculine and feminine traits that are minimally influenced by 
environmental factors. Further, a delayed pubertal onset would impact additional 
developmental processes (e.g., growth, thyroid, and appetite hormones) that we were unable 
to capture in this sample, which may also play a role in behavior.
The phenotypes included in our study and the assessment methods used may also not be the 
ideal phenotypes and measurement methods to detect a defeminization effect. We were able 
to identify differences in symptom ratings (e.g., state anxiety). However, no differences 
emerged for diagnosis suggesting symptomatology in general may be altered, but specific 
diagnoses are not. Our sample also included both acutely ill and recovered women with AN, 
and we were unable to determine the specific criteria for AN fulfilled or amenorrhea status 
at the time of assessment, which may have contributed to sample heterogeneity. However, 
we found no significant difference between the groups for current illness status or current 
BMI and controlled for current illness status in analyses, therefore effects of this 
heterogeneity are likely decreased.
Finally, decreased scores on novelty seeking and impulsivity measures are characteristic 
features of AN, and several significant differences were observed for eating disorder 
features based on the presence of primary amenorrhea. Women with primary amenorrhea 
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had a significantly younger age at low weight, longer duration of illness, and lower lifetime 
lowest BMI. Effect sizes for these differences indicated that all are likely clinically 
meaningful as they clustered around a medium effect. Together, this suggests that women 
with AN experiencing primary amenorrhea may reflect more prototypic cases of AN and 
that group differences in eating disorder features may also be due to the primary amenorrhea 
group being more severe, overall, across the course of their illness.
In sum, in regard to sex typical behaviors, our findings do not provide significant evidence 
for attenuated feminization in women with AN who experienced primary amenorrhea—
which may be due to the limitations of design described above. However, our study is one of 
the first to examine the organizational effects of gonadal hormones at puberty on 
characteristic masculine and feminine traits in humans without genetic disorders. More 
definitive conclusions could be reached using a prospective study design that assesses 
hormone levels at regular intervals in a large sample of girls beginning in childhood. This 
type of developmental, longitudinal approach would further clarify hormonal effects on sex-
specific behaviors in both healthy women and women with AN.
Acknowledgements
Although we did not conduct genotyping analyses in these studies, we should note that genotyping services for the 
larger project were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a 
federal contract from the National Institutes of Health to The Johns Hopkins University, Contract Number 
HHSN268200782096C. Dr. Baker was supported by National Institute of Health grant T32MH076694 (PI: Bulik). 
Dr. Strober receives support from the Franklin Mint Endowed Chair in Eating Disorders. We express our gratitude 
to all families who participated in this research.
References
Beach FA, Holz AM. Mating behavior in male rats castrated at various ages and injected with 
androgen. The Journal of Experimental Zoology. 1946; 101:91–142. [PubMed: 21016958] 
Berenbaum SA, Beltz AM. Sexual differentiation of human behavior: Effects of prenatal and pubertal 
organizational hormones. Frontiers in Neuroendocrinology. 2011; 32:183–200. [PubMed: 
21397624] 
Berenbaum SA, Bryk KL, Beltz AM. Early androgen effects on spatial and mechanical abilities: 
evidence from congenital adrenal hyperplasia. Behavioral Neuroscience. 2012; 126:86–96. 
[PubMed: 22289044] 
Buehren K, Konrad K, Schaefer K, Kratzsch J, Kahraman-Lanzerath B, Lente C, Herpertz-Dahlmann 
B. Association between neuroendocrinological parameters and learning and memory functions in 
adolescent anorexia nervosa before and after weight recovery. Journal of Neural Transmission. 
2011; 118:963–968. [PubMed: 21207075] 
Chui HT, Christensen BK, Zipursky RB, Richards BA, Hanratty MK, Kabani NJ, Katzman DK. 
Cognitive function and brain structure in females with a history of adolescent-onset anorexia 
nervosa. Pediatrics. 2008; 122:e426–e437. [PubMed: 18676530] 
Cloninger, CR.; Przybeck, TR.; Svrakic, DM.; Wetzel, RD. The Temperament and Character 
Inventory (TCI): A Guide to its Development and Use. St. Louis, MO: Center for Psychobiology of 
Personality. Washington University; 1994. 
Cohen-Bendahan CC, van de Beek C, Berenbaum SA. Prenatal sex hormone effects on child and adult 
sex-typed behavior: methods and findings. Neuroscience and Biobehavioral Reviews. 2005; 
29:353–384. [PubMed: 15811504] 
Fichter M, Herpertz S, Quadflieg N, Herpertz-Dahlmann B. Structured interview for anorexic and 
bulimic disorders for DSM-IV and ICD-10: updated (third) revision. International Journal of Eating 
Baker et al. Page 9






















Disorders. 1998; 24:227–249. doi:10.1002/(SICI)1098-108X(199811)24-3<227::AID-
EAT1>3.0.CO;2-O. [PubMed: 9741034] 
Field EF, Whishaw IQ, Forgie ML, Pellis SM. Neonatal and pubertal, but not adult, ovarian steroids 
are necessary for the development of female-typical patterns of dodging to protect food item. 
Behavioral Neuroscience. 2004; 118:1293–1304. [PubMed: 15598138] 
First, M.; Spitzer, R.; Gibbon, M.; Williams, J. Structured Clinical Interview for DSM-IV Axis I 
Disorders, Research Version, Patient Edition. New York: Biometrics Research, New York State 
Psychiatric Institute; 1997. 
Goodman W, Price L, Rasmussen S, Mazure C, Fleischmann R, Hill C, Charney D. The Yale-Brown 
Obsessive-Compulsive Scale (Y-BOCS): I. development, use, and reliability. Archives of General 
Psychiatry. 1989; 46:1006–1011. [PubMed: 2684084] 
Hebebrand J, Himmelmann GW, Heseker H, Schafer H, Remschmidt H. Use of percentiles for the 
body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations. 
International Journal of Eating Disorders. 1996; 19:359–369. doi:10.1002/
(SICI)1098-108X(199605)19:4<359::AID-EAT4>3.0.CO;2-K. [PubMed: 9156689] 
Hines M. Gender development and the human brain. Annual Review of Neuroscience. 2011; 34:69–
88.
Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the 
National Comorbidity Survey Replication. Biological Psychiatry. 2007; 61:348–358. [PubMed: 
16815322] 
Katzman DK, Lambe EK, Mikulis DJ, Ridgley JN, Goldbloom DS, Zipursky RB. Cerebral gray matter 
and white matter volume deficits in adolescent girls with anorexia nervosa. Journal of Pediatrics. 
1996; 129:794–803. [PubMed: 8969719] 
Katzman DK, Zipursky RB, Lambe EK, Mikulis DJ. A longitudinal magnetic resonance imaging study 
of brain changes in adolescents with anorexia nervosa. Archives of Pediatrics & Adolescent 
Medicine. 1997; 151:793–797. [PubMed: 9265880] 
Kaye WH, Lilenfeld LR, Berrettini WH, Strober M, Devlin B, Klump KL, McConaha CW. A search 
for susceptibility loci for anorexia nervosa: methods and sample description. Biological 
Psychiatry. 2000; 47:794–803. [PubMed: 10812038] 
Kaye WH, Plotnicov K, Thornton L, Devlin B, Fichter MM, Treasure J, Jones I. The Genetics of 
Anorexia Nervosa (GAN) Collaborative Study: Methods and sample description. International 
Journal of Eating Disorders. 2008; 41:289–300. [PubMed: 18236451] 
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Kendler KS. Lifetime and 
12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the 
National Comorbidity Survey. Archives of General Psychiatry. 1994; 51:8–19. [PubMed: 
8279933] 
Klump KL, Bulik CM, Pollice C, Halmi KA, Fichter MM, Berrettini WH, Kaye WH. Temperament 
and character in women with anorexia nervosa. Journal of Nervous and Mental Disease. 2000; 
188:559–567. [PubMed: 11009328] 
Mainz V, Schulte-Ruther M, Fink GR, Herpertz-Dahlmann B, Konrad K. Structural brain 
abnormalities in adolescent anorexia nervosa before and after weight recovery and associated 
hormonal changes. Psychosomatic Medicine. 2012; 74:574–582. [PubMed: 22511729] 
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in 
Childhood. 1969; 44:291–303. [PubMed: 5785179] 
Master-Hunter T, Heiman DL. Amenorrhea: evaluation and treatment. American Family Physician. 
2006; 73:1374–1382. [PubMed: 16669559] 
McDowell MA, Brody DJ, Hughes JP. Has age at menarche changed? Results from the National 
Health and Nutrition Examination Survey (NHANES) 1999–2004. Journal of Adolescent Health. 
2007; 40:227–231. [PubMed: 17321422] 
McLean CP, Anderson ER. Brave men and timid women? A review of the gender differences in fear 
and anxiety. Clinical Psychology Review. 2009; 29:496–505. [PubMed: 19541399] 
Mueller SC. Magnetic resonance imaging (MRI) in paediatric psychoneuroendocrinology: a new 
frontier for understanding the impact of hormones on emotion and cognition. Journal of 
Neuroendocrinology. 2013
Baker et al. Page 10






















Neufang S, Specht K, Hausmann M, Gunturkun O, Herpertz-Dahlmann B, Fink GR, Konrad K. Sex 
differences and the impact of steroid hormones on the developing human brain. Cerebral Cortex. 
2009; 19:464–473. [PubMed: 18550597] 
Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Reich 
TD. Diagnostic Interview for Genetic Studies: rationale, unique features, and training. Archives of 
General Psychiatry. 1994; 51:849–859. [PubMed: 7944874] 
Patton JM, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. Journal of 
Clinical Psychology. 1995; 51:768–774. doi:10.1002/1097-4679(199511)51:6<768::AID-
JCLP2270510607>3.0.CO;2-1. [PubMed: 8778124] 
Peters PJ, Bronson FH, Whitsett JM. Neonatal castration and intermale aggression in mice. Physiology 
& Behavior. 1972; 8:265–268. [PubMed: 4677206] 
Phoenix C, Roy RW, Gerall AA, Young WC. Organizing action of prenatally administered 
testosterone propionate on the tissues mediating mating behavior in the female guinea pig. 
Endocrinology. 1959; 65:359–382.
Pinheiro A, Thornton L, Plotonicov K, Tozzi T, Klump K, Berrettini W, Bulik C. Patterns of menstrual 
disturbance in eating disorders. International Journal of Eating Disorders. 2007; 40:424–434. 
[PubMed: 17497704] 
SAS Institute Inc.. SAS/STAT® Software: Version 9. Cary, NC: SAS Institute, Inc.; 2004. 
Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA. Shyness, social anxiety, and 
impaired self-esteem in Turner syndrome and premature ovarian failure. Journal of the American 
Medical Association. 2006; 295:1374–1376. [PubMed: 16551707] 
Schulz KM, Molenda-Figueira HA, Sisk CL. Back to the future: the organizational-activational 
hypothesis adapted to puberty and adolescence. Hormones and Behavior. 2009; 55:597–604. 
[PubMed: 19446076] 
Schulz KM, Sisk CL. Gonadal hormones masculinize and defeminize reproductive behaviors during 
puberty in the male Syrian hamster. Hormones and Behavior. 2004; 45:242–249. [PubMed: 
15053940] 
Sisk CL, Zehr JL. Pubertal hormones organize the adolescent brain and behavior. Frontiers in 
Neuroendocrinology. 2005; 26:163–174. [PubMed: 16309736] 
Skuse DH, Morris JS, Dolan RJ. Functional dissociation of amygdala-modulated arousal and cognitive 
appraisal, in Turner syndrome. Brain. 2005; 128:2084–2096. [PubMed: 15947057] 
Spielberger, C.; Gorsuch, R.; Luchene, R. The State-Trait Anxiety Inventory: Test manual for Form X. 
Palo Alto, CA: Consulting Psychologists Press; 1970. 
Taylor GT, Frechmann T, Royalty J. Social behaviour and testicular activity of juvenile rats. The 
Journal of Endocrinology. 1986; 110:533–537. [PubMed: 3760746] 
Baker et al. Page 11











































Baker et al. Page 12
Table 1











Age Low Weight 17.43 (5.00) 19.40 (6.00) 5.00* 0.36
Current BMI 19.45 (2.52) 19.32 (2.52) 0.10 0.05
Lifetime highest BMI 22.30 (2.38) 22.01 (2.94) 4.10 0.10
Lifetime lowest BMI 14.00 (2.11) 14.70 (1.90) 6.60* 0.35
Duration of Illness (years) 10.54 (8.06) 9.30 (8.32) 6.62* 0.16
Temperament and Character Inventory
Novelty Seeking 14.65 (6.65) 17.45 (6.72) 11.08** 0.41
Harm Avoidance 20.47 (7.74) 20.53 (7.51) 0.07 0.01
Barratt Impulsiveness Scale-II
Cognitive 16.78 (4.11) 17.20 (4.48) 0.64 0.10
Non-planning 22.12 (4.70) 23.26 (4.95) 3.70 0.24
Motor 19.32 (3.74) 20.35 (4.11) 5.21* 0.26
State-Trait Anxiety Inventory Form Y
State Anxiety 41.65 (13.38) 45.15 (13.68) 5.00* 0.26
Trait Anxiety 48.40 (13.20) 50.00 (13.70) 1.32 0.12
Yale-Brown Obsessive Compulsive Scale
Obsessions 5.88 (5.54) 6.21 (6.15) 0.21 0.06
Compulsions 6.86 (5.79) 6.75 (6.43) 0.01 0.02
Note. SD = standard deviation. BMI = body mass index. Chi-square values represent group comparisons from the logistic regression analyses. 
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